Posts about:
Modern name, purpose, and visual identity mark inspiring next chapter for maker of iconic, trusted brands, including Tylenol, Neutrogena, Listerine, and Band-Aid Brand
Bern, Switzerland, and Boston, USA September 28, 2022 – RetinAI Medical AG (“RetinAI”), is a leader in clinical and imaging data management software and advanced analytics for ophthalmology, is excited to announce the launch of its first U.S.-based office, located in Boston, MA. This expansion will support further growth within the U.S. market, building upon existing collaborations with U.S.-based pharmaceutical companies and its partnership with Heidelberg Engineering to distribute RetinAI’s Disease AI Apps for research use in the U.S. The Boston office will be RetinAI’s second location, in addition to its Bern headquarters.
LEIDEN, the Netherlands, September 26, 2022 / B3C newswire / -- SeraNovo BV (Leiden, The Netherlands) is pleased to announce the closing of a multi compound deal with Ildong Pharmaceutical (Seoul, South Korea), a pharmaceutical company engaged in the research and development of small molecules in the field of neuroscience and oncology.
Novo Nordisk Foundation launches major investment to develop the first quantum computer dedicated to life sciences research and the green transition
New facility adds supply assurance and capacity to enable more life-saving vaccines and therapies
Significant investment will enable world-class discovery research, innovation in data science and digital health and collaborations in the Bay Area
–Gilead Foundation’s Creating Possible Fund™ Reflects Broad and Ongoing Commitment to Health Equity –
NEW YORK, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, today announced its partnership with TMA Precision Health, a company on a mission to improve the lives of rare disease patients everywhere, offering clinical whole genome sequencing to rare disease patients as the first step in diagnosing and treating disease with more personalized medicine.
Bagsværd, Denmark and Redmond , W A , US , 12 September 2022 – Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence (AI) with Novo Nordisk’s drug discovery, development and data science capabilities.
National effort builds on Foundation’s longstanding commitment to helping patients in underserved communities receive high-quality, equitable care
